Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/16/17 → 4/15/20 |
Financiación
- Crestovo LLC: 13.510,00 US$
16-ID-203: A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects with Recurrence of Clostridium Difficile Infection
- Greenberg, Richard (PI)
- Caudill, Timothy (CoI)
- Flomenhoft, Deborah (CoI)
- Myint, Thein (CoI)